Literature DB >> 11668077

Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction.

M C Daniëls1, R S Keller, P P de Tombe.   

Abstract

We studied the effects of chronic losartan (Los) treatment on contractile function of isolated right ventricular (RV) trabeculae from rat hearts 12 wk after left ventricular (LV) myocardial infarction (MI) had been induced by ligation of the left anterior descending artery at 4 wk of age. After recovery, one-half of the animals were started on Los treatment (MI+Los; 30 mg x kg(-1) x day(-1) per os); the remaining animals were not treated (MI group). Rats without infarction or Los treatment served as controls (Con group). MI resulted in increases in LV and RV weight and unstressed LV cavity diameter; these were partially prevented by Los treatment. The active peak twitch force-sarcomere length relation was depressed in MI compared with either Con or MI+Los. Likewise, maximum Ca2+ saturated twitch force was depressed in MI, whereas twitch relaxation and twitch duration were prolonged. Myofilament function, as measured in skinned trabeculae, was not significantly different among the Con, MI, and MI+Los groups. We conclude that Los prevents contractile dysfunction in rat RV trabeculae after LV MI. Our results suggest that the beneficiary effect of Los treatment results not from improved myofilament function but rather from improved myocyte Ca2+ homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668077     DOI: 10.1152/ajpheart.2001.281.5.H2150

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

Authors:  Jie Liu; Catherine Gu; E Bernadette Cabigas; Karl D Pendergrass; Milton E Brown; Ying Luo; Michael E Davis
Journal:  Biomaterials       Date:  2013-02-19       Impact factor: 12.479

2.  Inhibition of ubiquitin protein expression and 20S proteasome activity by irbesartan prevents post-infarction ventricular remodeling and decreases TNF-α generation.

Authors:  Naiju Zhang; Tianping Chen; Chunfang Liu; Bi Tang; Ling Nie; Huiling An; Duilan Zhao; Li Pan; Meiling Yu
Journal:  Biomed Rep       Date:  2013-09-12

3.  Right ventricular dysfunction following acute myocardial infarction in the absence of pulmonary hypertension in the mouse.

Authors:  Stefano Toldo; Herman J Bogaard; Benjamin W Van Tassell; Eleonora Mezzaroma; Ignacio M Seropian; Roshanak Robati; Fadi N Salloum; Norbert F Voelkel; Antonio Abbate
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

4.  Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats.

Authors:  Namsik Yoon; Kye Hun Kim; Keun Ho Park; Doo Sun Sim; Hyun Ju Youn; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  Korean Circ J       Date:  2013-10-30       Impact factor: 3.243

5.  Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure.

Authors:  Namsik Yoon; Jeong Gwan Cho; Kye Hun Kim; Keun Ho Park; Doo Sun Sim; Hyun Ju Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jong Chun Park
Journal:  Exp Ther Med       Date:  2013-01-23       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.